INTRODUCTION
Diltiazem hydrochloride (DTZ) is a calcium channel blocker belonging to the benzothiazepine family. It is widely prescribed for the treatment of hypertension and angina. It has an elimination half-life of 3.5 h and an absorption zone from the upper intestinal tract. Efficacy of the administered dose may get diminished due to incomplete drug release from the device above the absorption zone. DTZ requires multiple daily drug dosage in order to maintain adequate plasma concentrations [1] . A suitable drug delivery system can improve controlled delivery of a drug exhibiting an absorption window by continuously releasing the drug for a prolonged period before it reaches the absorption site, thus ensuring its optimal bioavailability [2, 3] .
Various approaches including floating systems, bioadhesive systems, swelling and expanding systems and high density systems have been successfully employed to improve the gastric residence time of a delivery system [4, 5] . Though highly efficient for gastroretention, floating systems suffer from a major disadvantage that they are effective only when the fluid level in the stomach is sufficiently high. However, as the stomach empties and the tablet is at the pylorus, the buoyancy of the dosage form may be impeded [6] . This serious limitation can be overcome by making the system eventually adhere to the mucous lining of the stomach wall.
Mucoadhesion has been an extensively adapted approach for achieving site-specific drug delivery through the amalgamation of mucoadhesive polymers within pharmaceutical formulations along with the active pharmaceutical ingredient (API). Mucoadhesive materials are hydrophilic macromolecules containing numerous hydrogen bond forming groups. The mechanism by which mucoadhesion takes place has been said to be in two stages: the contact (wetting) stage followed by the consolidation stage (establishment of adhesive interactions) [7] .
The objective of the current study was to develop bioadhesive tablets of diltiazem hydrochloride and optimize their bioadhesive and drug release characteristics using the benefits of central composite design methodology [8] .
EXPERIMENTAL Materials
Diltiazem hydrochloride, Carbopol 934P and HPMC K4M were obtained as gifts from Modi Mudi Pharmaceuticals, Meerut and all other chemicals used were of analytical grade.
Preparation of Bioadhesive Tablets
Different bioadhesive tablet formulations of diltiazem hydrochloride were formulated using varying amount of two polymers (carbopol and HPMC) and Microcrystalline cellulose as diluent, which does not interfere with the floating property of the tablets due to its low bulk density [9] along with fixed quantity of talc and magnesium stearate as glidant and lubricant respectively. All ingredients, except magnesium stearate, were passed through 200 µ aperture sieve and then mixed for 20 min. Finally, Magnesium stearate was added into powder blend as a lubricant and mixed for an additional 3 min before compaction process. Then, 360 mg tablets containing 90 mg diltiazem hydrochloride were prepared by a lab press [8] . The tablet formulations are shown in Table 1 . 
Experimental design
A central composite design (CCD) for two factors at three levels each (α = 1) was selected to optimize the varied response variables. The two factors, viz., polymer X 1 (CP) and polymer X 2 (HPMC) of each polymer bland, were varied as required by the experimental design and the factor level were suitably coded ( Table 2 ). The extent of drug release in 12 h (Q 12) , time to release 60 % (t 60% ) and bioadhesive strength (BS) were taken as responsive variables [10] . Coded factor
Translation of coded levels in actual units 
Physical characterization of diltiazem tablets
The formulated tablets were subjected to the following physical characterization studies. The drug content of each batch of the formulated tablets was determined in triplicate by UV-visible method at 237nm. The weight variation was determined based on 20 tablets using electronic balance. Mean tablet hardness was determined on six tablets from each batch using Monsanto tablet hardness tester. Friability was determined (n = 10) using Roche friabilator for 5 min at 25 rpm, while thickness was determined using vernier calipers.
Measurement of bioadhesive strength of tablets
Gastric mucosa of goat was used as the model membrane for ex vivo measurement of bioadhesive strength. The mucosal membrane was excised by removing the underlining connective tissues. The mucosa was tied on the slide and the slide was fixed in the petri plate filled with distilled water and the petri plate was placed inside the left arm of the physical balance. The tablet was fixed on the left pan of the physical balance. The left arm was lowered until a tablet contact with the membrane was made. A contact force of 10 g was placed on the left arm for 5 min. After 5 min, the weight was removed from the left pan and the assembly was kept undisturbed. Weight was slowly added on the right hand side pan until the tablet just got detached from the membrane surface. The peak detachment force was recorded as a measure of bioadhesive strength [11] .
Swelling index
Tablets were weighed (W 1 ) individually and placed in a USP XXII paddle method (apparatus 2) (model DS 8000, Lab India) containing 900 ml 0.1N HCl, stirred at 50 rpm and maintained at 37 ± 0.5 °C. At regular intervals, the tablets were removed from the dissolution apparatus, excess water removed carefully using filter paper and reweighed (W 2 ). Swelling index (S) of each tablet was calculated by using following formula [12] :
In vitro drug release studies
Dissolution studies were carried out on all the tablet formulations in triplicate, employing USP XXII paddle method (Apparatus 2) at 50 rpm and 37 ± 0.5 °C, using 900 ml simulated gastric fluid (SGF) pH 1.2 without pepsin as the dissolution medium. Five ml of sample was withdrawn periodically at suitable time intervals and replaced with an equivalent volume of fresh dissolution medium. The withdrawn samples were analyzed by UV Spectrophotometer (UV 1800 Shimadzu) at 237 nm. Drug release data obtained were analyzed using Zorel software [13] which has in-built provisions for applying the correction factor for volume and drug losses during sampling [14] .
The drug release data were fitted to Korsemeyer-Peppas model (Eq 2) [15] . Mt / M∞ = k 1 t n + k 2 t 2n ……………………… (2) where, M t is amount of drug released at time 't', M ∞ is amount of drug released at an infinite time, k 1 is the magnitudinal contribution of diffusion mechanism, k 2 is the magnitudinal contribution of polymer relaxation mechanism, and n is the Fickian diffusion coefficient.
Based on phenomenological analysis, the type of release (i.e., whether Fickian, non-Fickian (anomalous) or zero order) was predicted [11] . t 60% value was calculated using Stineman interpolation option of the Graph 2.0 software (M/s Micromath Inc, St Louis, USA).
Optimization data analysis and validation of optimization model
The response variables which were considered for systematic optimization included t 60 %, Q 12 and BS. For the studied design, multiple linear regression analysis (MLRA) method was applied to fit full second-order polynomial equation with added interaction terms to correlate the studied responses with the examined variables using Design expert software version 8.0.5 (Stat-Ease, USA 45days trial version). The polynomial regression results were demonstrated for the studied responses. Finally, the prognosis of optimum formulation was conducted using a twostage brute force technique using MS-Excel spreadsheet software. First, a feasible space was located and second, an exhaustive grid search was conducted to predict the possible solutions. Six formulations were selected as the confirmatory check-points to validate RSM. The observed and predicted responses were critically compared. Linear correlation plots were constructed for the chosen eight optimized formulations. The residual graphs between predicted and observed responses were also constructed separately, and the percent bias (= prediction error) was calculated with respect to the observed responses [11] .
RESULTS

Physicochemical characteristics of the tablets
Physical appearance, tablet hardness, friability, weight variation, and drug content uniformity of all formulations were satisfactory, as shown in Tables 3. It was observed that all the tablets showed acceptable physicochemical properties. 
Bioadhesive strength of tablets
The bioadhesive strength of the tablets ranged between 7.6 to 21 g, and increased with increase in the concentration of the polymer in the tablet; However, this effect was more pronounced for Carbopol. Table 1 . 
In vitro drug release
Response surface analysis
The coefficient of the polynomial equation (Eq 2) generated using MLRA for Q 12h , t 60% and BS of the tablet, formed excellent fits to the data, with quite high value of r 2 ranging between 0.9898 and 0.999. Y= β 0 + β 1 X 1 + β 2 X 2 + β 3 X 1 X 2 + β 4 X 1 2 + β 5 X 2 2 + β 6 X 1 X 2 2 + β 7 X 1
X -------------------(3)
Seven coefficients (β 1 to β 7 ) were calculated representing β 0 as intercept, and β 3 to β 7 various quadratic and interaction terms.
Figs 2 to 4 show the various three dimensional response surface plots for the studied response properties, viz, t 60%, Q 12, and BS. Fig 2 Showed a linear increasing trends in the value of t 60% with increase in the amount of either polymer but the influence of CP wass more significant than HPMC, indicating that the former has better release controlling properties than the latter. Hence, the higher levels of CP have to be complemented with lower levels of HPMC and vice-versa to maintain the value of t 60% at a constant level. Nonlinear descending lines elucidate that the variation in Q 12 is a function of polymer levels, the effect of HPMC being less significant. 4 shows nearly linear ascending pattern for the values of bioadhesive strength as the content of either polymer increased in the formulation and the effect of CP is more prominent than HPMC. The maximum bioadhesive strength was observed at the highest levels of both the polymers. The results are in consonance with literature reports stating high contribution of carbomers in attainment of bioadhesive strength in hydrophillic matrices [10] .
Selection of optimized formulation
The optimum formulation was selected by trading off various response variables and adopting the following maximizing criteria: t 60% > 5.0 h, Q 12 > 88%, BS > 12. Upon comprehensive evaluation of grid searches, the formulation (CP 84 mg, HPMC 90 mg) fulfilled the optimal criteria of best regulation of the release rate and bioadhesive characteristics with t 60% of 5.33 h, Q 12h of 90.95 % and bioadhesive strength of 12.79 g. Thus, besides controlling drug release, the formulation has definite gastroretentive potential to retain the drug in the gastric environment and upper part of intestine. 
Validation of response surface methodology results
Linear
DISCUSSION
The present investigation describes the development of an optimized gastric bioadhesive tablet formulation of diltiazem hydrochloride. A combination of ionic polymer (such as CP) and nonionic polymer (such as HPMC) were choosen because they are known to provide a formulation with controlled drug release and/or desired mucoadhesive properties [17] .
Bioadhesive strength increased with increase in the content of either polymer, an observation that has previously been made [16] . Hydrogels are known to swell readily on contact with the hydrated mucous membrane [17] . Water sorption reduces glass transition temperature below ambient conditions, and hydrogels become progressively rubbery due to uncoiling of polymer chains and subsequent increased mobility of the polymer chains. The glassrubbery transition provides hydrogel plasticization, resulting in a large adhesive surface for maximum contact with mucin and flexibility to the polymer chain for interpenetration with mucin. Increasing the polymer amount may provide more adhesive sites and polymer chains for interpenetration with mucin, resulting in augmentation of bioadhesive strength. Although the maximum value of bioadhesive strength was attained at higher levels of both polymers and the effect carbopol on the bioadhesion was distinctly more pronounced than that of HPMC. The swelling of the formulation increased as the amount of either polymer increase in the tablet but the effect of HPMC on the swelling was more pronounced than that of carbopol due to the hydrophilic nature of the former.
The bioadhesive tablets showed values of n ranging between 0.4911 and 0.6585, indicating the non-Fickian release behaviour of all formulations. The values of n showed increasing trend with increase in HPMC content, even at higher levels of Carbopol. on the other hand, the kinetic constant, k, showed a decline with increase in the content of either polymer.
Relatively much higher magnitude of Fickian diffusion constant, k 1 vis-à-vis the polymer relaxation constant, k 2 clearly showed that drug release was predominantly determined by Fickian diffusion, with a negligible contribution of polymer relaxation. This is in agreement with earlier findings that a mixture of HPMC and Carbopol resulted in the reduction of polymer viscosity due to reduced hydration [11, 18] .
This reduction of viscosity could facilitate drug diffusion through polymer hydrogel. The overall rate of drug release tended to decrease with increase in the concentration of either HPMC or carbopol. Similarly, the values of Q 12h decreased with increase in polymer content. However, the values of t 60% increased from 4.95 to 7.78 h for both polymers.
In Central Composite Design (CCD), all the factors are studied for all plausible combinations, as it is considered to be most efficient in estimating the influence of individual variables and their interactions, using minimum experimentation. Hence, CCD for two factors at three levels with a = 1 was chosen. The high values of r 2 exhibited by the polynomial relationships vouched high statistical validity (p < 0.001) of Equation 2 for fitting to the experimental data. The amounts of CP and HPMC had a positive influence on the values of coefficients of t 60 %, the effect being more apparent with HPMC. On the other hand, the positive effect of CP is vividly far more pronounced than that of HPMC in regulating the values of BS.
CONCLUSION
Suitable balancing between the levels of the two polymers (CP and HPMC) is imperative to attaining maximum prolongation of drug release and adequate bioadhesive strength. The bioadhesive nature of the formulation may prolong gastrointestinal (GI) residence time thus ensuring maximum absorption. The optimized formulation showed good controlled release and bioadhesive characteristics indicating the success of experimental approach employeded.
